BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12905770)

  • 21. The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.
    Ziegler AI; Le Page MA; Maxwell MJ; Stolp J; Guo H; Jayasimhan A; Hibbs ML; Santamaria P; Miller JF; Plebanski M; Silveira PA; Slattery RM
    Diabetologia; 2013 Dec; 56(12):2659-68. PubMed ID: 24013782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Fas but not Fas ligand on fetal pig beta cells.
    Bai L; Maedler K; Donath M; Tuch BE
    Xenotransplantation; 2004 Sep; 11(5):426-35. PubMed ID: 15303979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of complete Freund's adjuvant on islet beta cell apoptosis and its mechanism in non-obese diabetic mice].
    Zhu L; Zhou ZG; Yang W; Yang ZL; Zhang S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):834-7. PubMed ID: 17213578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes.
    Sainio-Pöllänen S; Liukas A; Pöllänen P; Simell O
    Pancreas; 1999 Apr; 18(3):282-93. PubMed ID: 10206487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral administration of insulin inhibits islet beta cell apoptosis and prevents diabetes in NOD mice].
    Jiang TJ; Zhou ZG
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):615-9. PubMed ID: 17767052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ; Zhou ZG; Su H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism.
    Suarez-Pinzon W; Korbutt GS; Power R; Hooton J; Rajotte RV; Rabinovitch A
    Diabetes; 2000 Nov; 49(11):1810-8. PubMed ID: 11078447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
    Lin B; Zhang ZL; Yu LY; Guo LH
    Acta Pharmacol Sin; 2003 Dec; 24(12):1199-204. PubMed ID: 14653944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation.
    Kaminitz A; Yolcu ES; Mizrahi K; Shirwan H; Askenasy N
    Int Immunol; 2013 Aug; 25(8):485-94. PubMed ID: 23657001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus.
    Moriwaki M; Itoh N; Miyagawa J; Yamamoto K; Imagawa A; Yamagata K; Iwahashi H; Nakajima H; Namba M; Nagata S; Hanafusa T; Matsuzawa Y
    Diabetologia; 1999 Nov; 42(11):1332-40. PubMed ID: 10550417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes.
    Kim YH; Kim S; Kim KA; Yagita H; Kayagaki N; Kim KW; Lee MS
    Eur J Immunol; 1999 Feb; 29(2):455-65. PubMed ID: 10064061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice.
    Wada T; Schwarting A; Kinoshita K; Naito T; Griffiths RC; Coffman TM; Kelley VR
    Kidney Int; 1999 Mar; 55(3):841-51. PubMed ID: 10027921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice.
    Mahiou J; Walter U; Lepault F; Godeau F; Bach JF; Chatenoud L
    J Autoimmun; 2001 Jun; 16(4):431-40. PubMed ID: 11437491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Fas in autoimmune diabetes.
    Chervonsky AV; Wang Y; Wong FS; Visintin I; Flavell RA; Janeway CA; Matis LA
    Cell; 1997 Apr; 89(1):17-24. PubMed ID: 9094710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
    Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
    Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune diabetes in the NOD mouse: an essential role of Fas-FasL signaling in beta cell apoptosis.
    Silva DG; Socha L; Charlton B; Cowden W; Petrovsky N
    Ann N Y Acad Sci; 2003 Nov; 1005():161-5. PubMed ID: 14679051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Fas ligand in the development of insulitis in nonobese diabetic mice.
    Sainio-Pöllänen S; Erkkilä S; Alanko S; Hänninen A; Pöllänen P; Simell O
    Pancreas; 1998 Mar; 16(2):154-9. PubMed ID: 9510138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.